Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers

European Respiratory Journal

Volumn 33, Issue 2, 2009, Pages 273-281

  Regueiro, V ^a,b   Campos, M A ^a,b   Morey, P ^a,b   Sauleda, J ^a,b   Agusti A G N ^a,b,c   Garmendia, J ^a,b   Bengoechea, J A ^a,b,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Fundacion Caubet CIMERA Illes Balears   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d Recinto Hospital Joan March   (Spain)

Author keywords

CD14; Haemophilus influenzae; Inflammation; Lipopolysaccharide binding protein

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; AGED; ARTICLE; CELL ADHESION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; HUMAN; INTERNALIZATION; LUNG FUNCTION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RISK FACTOR; SIGNAL TRANSDUCTION;

ACUTE-PHASE PROTEINS; ANTIGENS, CD14; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER PROTEINS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS INFLUENZAE; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; LUNG; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 59649128745     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00087708     Document Type: Article

References (32)

1. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003; 16: 379-14.
2. Zweigner J, Schumann RR, Weber JR. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect 2006; 8: 946-952.
3. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
4. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004; 172: 4470-4479.
5. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothe-lial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90: 2744-2748.
6. Jack RS, Fan X, Bernheiden M, et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997; 389: 742-745.
7. Yang KK, Dorner BG, Merkel U, et al. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J Immunol 2002; 169: 4475-4480.
8. Martin TR, Rubenfeld GD, Ruzinski JT, et al. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 937-944.
9. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 1584-1589.
10. Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Kawase H, Sekine I. Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 2000; 119: 376-381.
11. Yu S, Nakashima N, Xu BH, et al. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysacchar-ides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 1998; 17: 237-243.
12. Ward C, Walters EH, Zheng L, Whitford H, Williams TJ, Snell GI. Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients. Eur Respir J 2002; 19: 472-478.
13. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003; 54: 113-129.
14. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
15. Fletcher CM. Chronic bronchitis. Its prevalence, nature, and pathogenesis. Am Rev Respir Dis 1959; 80: 483-494.
16. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
17. Barcelo B, Pons J, Fuster A, et al. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006; 145: 474-479.
18. Regueiro V, Campos MA, Pons J, Alberti S, Bengoechea JA. The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells. Microbiology 2006; 152: 555-566.
19. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 2004; 30: 500-509.
20. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7: 147-159.
21. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311: 1413-1418.
22. Li JD. Exploitation of host epithelial signaling networks by respiratory bacterial pathogens. J Pharmacol Sci 2003; 91: 1-7.
23. Dubin W, Martin TR, Swoveland P, et al. Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol 1996; 270: L736-L744.
24. Dentener MA, Vreugdenhil AC, Hoet PH, et al. Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol 2000; 23: 146-153.
25. Moeenrezakhanlou A, Nandan D, Shephard L, Reiner NE. 1α, 25-dihydroxycholecalciferol activates binding of CREB to a CRE site in the CD14 promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent manner. J Leukoc Biol 2007; 81: 1311-1321.
26. Schumann RR, Kirschning CJ, Unbehaun A, et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 1996; 16: 3490-3503.
27. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 1-20.
28. Stylianou E, Saklatvala J. Interleukin-1. lnt J Biochem Cell Biol 1998; 30: 1075-1079.
29. Rahman I. Regulation of nuclear factor-κB, activator protein-1, and glutathione levels by tumor necrosis factor-α and dexamethasone in alveolar epithelial cells. Biochem Pharmacol 2000; 60: 1041-1049.
30. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipo-protein. J Exp Med 1995; 181: 1743-1754.
31. Clemans DL, Bauer RJ, Hanson JA, et al. Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect Immun 2000; 68: 4430-440.
32. Frick AG, Joseph TD, Pang L, Rabe AM, St Geme JW III, Look DC. Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells. J Immunol 2000; 164: 4185-4196.